Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Change in Accured Expenses (2023 - 2025)

Historic Change in Accured Expenses for Cresco Labs (CRLBF) over the last 3 years, with Q3 2025 value amounting to -$5.3 million.

  • Cresco Labs' Change in Accured Expenses fell 13387.37% to -$5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$21.1 million, marking a year-over-year decrease of 16523.32%. This contributed to the annual value of -$15.5 million for FY2024, which is 15590.57% down from last year.
  • Per Cresco Labs' latest filing, its Change in Accured Expenses stood at -$5.3 million for Q3 2025, which was down 13387.37% from -$10.6 million recorded in Q2 2025.
  • Cresco Labs' 5-year Change in Accured Expenses high stood at $20.1 million for Q1 2023, and its period low was -$19.1 million during Q4 2024.
  • In the last 3 years, Cresco Labs' Change in Accured Expenses had a median value of -$5.2 million in 2024 and averaged $932272.7.
  • In the last 5 years, Cresco Labs' Change in Accured Expenses plummeted by 14558.51% in 2024 and then soared by 30150.53% in 2025.
  • Quarter analysis of 3 years shows Cresco Labs' Change in Accured Expenses stood at -$11.5 million in 2023, then crashed by 65.93% to -$19.1 million in 2024, then soared by 72.2% to -$5.3 million in 2025.
  • Its Change in Accured Expenses was -$5.3 million in Q3 2025, compared to -$10.6 million in Q2 2025 and $13.9 million in Q1 2025.